Israeli AI medical imaging firm Aidoc is teaming up with icometrix, a world leader in imaging AI solutions for patients with neurological conditions, to provide an AI-based stroke suite for rapid triage of patients with suspected stroke.
Follow Israel Hayom on Facebook and Twitter
The suite, which features Aidoc's FDA-cleared AI stroke solution for flagging and communication of large-vessel occlusion and intracranial hemorrhage and icometrix's FDA-cleared icobrain-cva for the analysis of the tissue perfusion state on CT perfusion scans in patients with ischemic stroke, is designed to alert physicians to the patient's condition, facilitate timely communication, and expand access to lifesaving treatment.
The suite is customizable and can also be provided with Aidoc's solution for flagging C-Spine Fractures and icometrix's MS/TBI AI solutions. At some point in the next few months, Aidoc's investigational solution for notification of brain aneurysm is expected to be installed, as well.
"The future of healthcare AI is partnerships that combine different advanced technologies synergistically into integrated clinical solutions. We're proud to partner with Aidoc to bring the most advanced end-to-end AI stroke package to patients." said icometric CCO Jennifer Young.
Three years ago, Aidoc released the industry-first solution for the flagging and notification of intracranial hemorrhage. Since then, it has analyzed over 3 million head CTs and demonstrated its utility in clinical practice in over 500 medical centers.
"As a trusted comprehensive enterprise AI partner, many health systems are asking us to expand to more and more of their radiology and multi-disciplinary workflows," said Demetri Giannikopoulos, Aidoc's VP of Innovation. "We've embraced the challenge and in addition to our recent PE, C-Spine Fracture and ICH Care Coordination solutions, we have now partnered with icometrix to bring the world's most robust AI stroke solution seamlessly integrated into the workflow of each physician."
Subscribe to Israel Hayom's daily newsletter and never miss our top stories!
